Experimental enzyme treatment reduces tumor growth in cancer study
Experimental enzyme treatment reduces tumor growth in cancer study Rare Cancer News
1636 материалов по теме, собраны автоматически из проверенных источников
Experimental enzyme treatment reduces tumor growth in cancer study Rare Cancer News
ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer News-Medical
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026 Yahoo Finance
WASHINGTON — Children were twice as likely to begin and complete the HPV vaccine series at clinics that began recommending it at ages 9 and 10 instead of ages 11 and 12, according to findings presented at IDWeek. The HPV vaccine provides protection against 6 types of cancer. The CDC recommends HPV vaccination starting…
Researchers at the University of Missouri have uncovered a promising way to protect saliva-producing glands from radiation damage that can make it difficult to eat, swallow, sleep and maintain oral hygiene.
Study Finds Geographic Gaps in TNBC Trial Access Persist Across US Targeted Oncology
Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, researchers from the MRC Laboratory of Medical Sciences (LMS), the University of Oxford and UCL have discovered a previously unknown role for Wee1 that could explain these effects.
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. MarketWatch
Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer BioSpace
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market GlobeNewswire
Clinical Trial Asks Whether Gut Health Influences Ovarian Cancer Treatment Outcomes Technology Networks
WASHINGTON — A new retrospective cohort study revealed that more than half of early childhood exposures to hepatitis B virus come from household members other than the birth mother. Researcher Karen B. Jacobson, MD, MPH, said the study’s shows that delaying HBV vaccination based strictly on maternal status puts…
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer The Manila Times
American Cancer Society research supports physical activity as part of comprehensive cancer survivorship care
Physical Activity After Cancer Diagnosis Linked to Lower Healthcare Costs Among Older Survivors, New Study Finds | Newswise Newswise